nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—HIF1A—brainstem—meningioma	0.0121	0.0541	CbGeAlD
Carvedilol—GJA1—brainstem—meningioma	0.0118	0.0525	CbGeAlD
Carvedilol—SELE—medulla oblongata—meningioma	0.00956	0.0426	CbGeAlD
Carvedilol—VCAM1—medulla oblongata—meningioma	0.0088	0.0392	CbGeAlD
Carvedilol—SELE—spinal cord—meningioma	0.00853	0.038	CbGeAlD
Carvedilol—HIF1A—medulla oblongata—meningioma	0.00846	0.0377	CbGeAlD
Carvedilol—GJA1—medulla oblongata—meningioma	0.00821	0.0366	CbGeAlD
Carvedilol—NPPB—brain—meningioma	0.00813	0.0362	CbGeAlD
Carvedilol—VCAM1—spinal cord—meningioma	0.00785	0.035	CbGeAlD
Carvedilol—HIF1A—spinal cord—meningioma	0.00755	0.0336	CbGeAlD
Carvedilol—GJA1—spinal cord—meningioma	0.00732	0.0326	CbGeAlD
Carvedilol—NDUFC2—medulla oblongata—meningioma	0.00715	0.0319	CbGeAlD
Carvedilol—SELE—cerebellum—meningioma	0.00676	0.0301	CbGeAlD
Carvedilol—NDUFC2—spinal cord—meningioma	0.00637	0.0284	CbGeAlD
Carvedilol—HIF1A—cerebellum—meningioma	0.00598	0.0267	CbGeAlD
Carvedilol—GJA1—cerebellum—meningioma	0.00581	0.0259	CbGeAlD
Carvedilol—VEGFA—spinal cord—meningioma	0.00578	0.0258	CbGeAlD
Carvedilol—SELE—brain—meningioma	0.00549	0.0245	CbGeAlD
Carvedilol—NDUFC2—cerebellum—meningioma	0.00505	0.0225	CbGeAlD
Carvedilol—VCAM1—brain—meningioma	0.00505	0.0225	CbGeAlD
Carvedilol—HIF1A—brain—meningioma	0.00486	0.0217	CbGeAlD
Carvedilol—GJA1—brain—meningioma	0.00472	0.021	CbGeAlD
Carvedilol—VEGFA—cerebellum—meningioma	0.00458	0.0204	CbGeAlD
Carvedilol—NDUFC2—brain—meningioma	0.0041	0.0183	CbGeAlD
Carvedilol—VEGFA—brain—meningioma	0.00372	0.0166	CbGeAlD
Carvedilol—ADRA1A—brainstem—meningioma	0.00349	0.0156	CbGeAlD
Carvedilol—ADRA1B—brain—meningioma	0.00249	0.0111	CbGeAlD
Carvedilol—ADRA1D—brain—meningioma	0.00243	0.0108	CbGeAlD
Carvedilol—KCNH2—medulla oblongata—meningioma	0.00235	0.0105	CbGeAlD
Carvedilol—ADRA2C—medulla oblongata—meningioma	0.00232	0.0103	CbGeAlD
Carvedilol—KCNH2—spinal cord—meningioma	0.0021	0.00934	CbGeAlD
Carvedilol—ADRA2C—spinal cord—meningioma	0.00207	0.00921	CbGeAlD
Carvedilol—CYP2D6—brainstem—meningioma	0.00205	0.00916	CbGeAlD
Carvedilol—ADRA2A—medulla oblongata—meningioma	0.00185	0.00824	CbGeAlD
Carvedilol—CYP2E1—medulla oblongata—meningioma	0.00181	0.00807	CbGeAlD
Carvedilol—ADRB1—brain—meningioma	0.00177	0.00788	CbGeAlD
Carvedilol—ADRA1A—cerebellum—meningioma	0.00172	0.00767	CbGeAlD
Carvedilol—KCNH2—cerebellum—meningioma	0.00166	0.0074	CbGeAlD
Carvedilol—ADRA2A—spinal cord—meningioma	0.00165	0.00735	CbGeAlD
Carvedilol—ADRA2C—cerebellum—meningioma	0.00164	0.00731	CbGeAlD
Carvedilol—CYP2E1—spinal cord—meningioma	0.00161	0.00719	CbGeAlD
Carvedilol—PTGS1—spinal cord—meningioma	0.00155	0.00693	CbGeAlD
Carvedilol—ADRA1A—brain—meningioma	0.0014	0.00623	CbGeAlD
Carvedilol—KCNH2—brain—meningioma	0.00135	0.00601	CbGeAlD
Carvedilol—ADRA2C—brain—meningioma	0.00133	0.00593	CbGeAlD
Carvedilol—ADRA2A—cerebellum—meningioma	0.00131	0.00583	CbGeAlD
Carvedilol—CYP2E1—cerebellum—meningioma	0.00128	0.0057	CbGeAlD
Carvedilol—CYP1A1—brain—meningioma	0.00114	0.00508	CbGeAlD
Carvedilol—ADRA2A—brain—meningioma	0.00106	0.00474	CbGeAlD
Carvedilol—CYP2E1—brain—meningioma	0.00104	0.00463	CbGeAlD
Carvedilol—ABCB1—medulla oblongata—meningioma	0.00103	0.00459	CbGeAlD
Carvedilol—CYP2D6—cerebellum—meningioma	0.00101	0.00452	CbGeAlD
Carvedilol—PTGS1—brain—meningioma	0.001	0.00446	CbGeAlD
Carvedilol—ABCB1—spinal cord—meningioma	0.000919	0.0041	CbGeAlD
Carvedilol—CYP2D6—brain—meningioma	0.000823	0.00367	CbGeAlD
Carvedilol—ADRB2—GPCR ligand binding—SMO—meningioma	0.000752	0.00097	CbGpPWpGaD
Carvedilol—ADRA2B—Platelet activation, signaling and aggregation—PDGFB—meningioma	0.000741	0.000955	CbGpPWpGaD
Carvedilol—VEGFA—VEGFA-VEGFR2 Pathway—AKT1—meningioma	0.00074	0.000954	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—TSHB—meningioma	0.000732	0.000943	CbGpPWpGaD
Carvedilol—ABCB1—cerebellum—meningioma	0.000729	0.00325	CbGeAlD
Carvedilol—HIF1A—Disease—PDGFB—meningioma	0.000727	0.000937	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR ligand binding—SMO—meningioma	0.000712	0.000918	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR ligand binding—SMO—meningioma	0.000701	0.000903	CbGpPWpGaD
Carvedilol—VEGFA—Signaling by VEGF—AKT1—meningioma	0.000698	0.0009	CbGpPWpGaD
Carvedilol—ADRA2C—Platelet activation, signaling and aggregation—PDGFB—meningioma	0.000692	0.000892	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—TSHB—meningioma	0.00068	0.000877	CbGpPWpGaD
Carvedilol—ADRA1B—AMPK Signaling—TP53—meningioma	0.000674	0.000869	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Breast Cancer Pathway—TP53—meningioma	0.000665	0.000858	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—SMO—meningioma	0.000665	0.000857	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—PDGFB—meningioma	0.000648	0.000836	CbGpPWpGaD
Carvedilol—XDH—Metabolism—TSHB—meningioma	0.000647	0.000834	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—PLAU—meningioma	0.000629	0.000811	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—SMO—meningioma	0.000622	0.000802	CbGpPWpGaD
Carvedilol—VEGFA—Axon guidance—ERBB2—meningioma	0.000621	0.0008	CbGpPWpGaD
Carvedilol—ADRA1B—LPA receptor mediated events—AKT1—meningioma	0.000605	0.00078	CbGpPWpGaD
Carvedilol—ADRA1A—AMPK Signaling—TP53—meningioma	0.000599	0.000772	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—ERBB2—meningioma	0.000596	0.000768	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—HES1—meningioma	0.000595	0.000768	CbGpPWpGaD
Carvedilol—ABCB1—brain—meningioma	0.000592	0.00264	CbGeAlD
Carvedilol—ADRA2A—GPCR ligand binding—SMO—meningioma	0.000578	0.000745	CbGpPWpGaD
Carvedilol—ADRA1B—AMPK Signaling—AKT1—meningioma	0.000569	0.000734	CbGpPWpGaD
Carvedilol—ADRA2A—Platelet activation, signaling and aggregation—PDGFB—meningioma	0.000562	0.000725	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Breast Cancer Pathway—AKT1—meningioma	0.000562	0.000724	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—TSHB—meningioma	0.000561	0.000723	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.000551	0.000711	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—PLAUR—meningioma	0.000528	0.000681	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—TSHB—meningioma	0.000511	0.000659	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—TSHB—meningioma	0.000509	0.000657	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—PDGFB—meningioma	0.000509	0.000656	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—PTEN—meningioma	0.000508	0.000655	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—TSHB—meningioma	0.000506	0.000653	CbGpPWpGaD
Carvedilol—ADRA1A—AMPK Signaling—AKT1—meningioma	0.000506	0.000652	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—TSHB—meningioma	0.0005	0.000645	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—PLAUR—meningioma	0.000494	0.000636	CbGpPWpGaD
Carvedilol—HIF1A—Disease—ERBB2—meningioma	0.000487	0.000628	CbGpPWpGaD
Carvedilol—VCAM1—Adaptive Immune System—AKT1—meningioma	0.000483	0.000622	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—TSHB—meningioma	0.000473	0.00061	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—ALAD—meningioma	0.000471	0.000607	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—ALAD—meningioma	0.00047	0.000606	CbGpPWpGaD
Carvedilol—VEGFA—Focal Adhesion—AKT1—meningioma	0.000467	0.000603	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—TSHB—meningioma	0.000466	0.0006	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000465	0.0006	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—TSHB—meningioma	0.000464	0.000598	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—TSHB—meningioma	0.000462	0.000596	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—TSHB—meningioma	0.000461	0.000594	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—TSHB—meningioma	0.00046	0.000593	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—TSHB—meningioma	0.000454	0.000585	CbGpPWpGaD
Carvedilol—NDUFC2—Metabolism—PTEN—meningioma	0.000451	0.000582	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—ERBB2—meningioma	0.000443	0.000571	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—SMO—meningioma	0.000433	0.000558	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—TSHB—meningioma	0.00043	0.000554	CbGpPWpGaD
Carvedilol—VEGFA—Cellular responses to stress—TP53—meningioma	0.000425	0.000549	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—TSHB—meningioma	0.000423	0.000545	CbGpPWpGaD
Carvedilol—HIF1A—Disease—PTEN—meningioma	0.000416	0.000536	CbGpPWpGaD
Carvedilol—VEGFA—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000414	0.000534	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—TSHB—meningioma	0.000414	0.000533	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—PLAUR—meningioma	0.000401	0.000517	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—SMO—meningioma	0.000395	0.000509	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—SMO—meningioma	0.000393	0.000506	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—SMO—meningioma	0.000392	0.000505	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—SMO—meningioma	0.000391	0.000504	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—SMO—meningioma	0.000386	0.000498	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—TSHB—meningioma	0.000384	0.000495	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—ALAD—meningioma	0.000383	0.000493	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—PDGFB—meningioma	0.000382	0.000492	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—PGR—meningioma	0.000377	0.000486	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—PGR—meningioma	0.000376	0.000484	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—TSHB—meningioma	0.000376	0.000484	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—PLAU—meningioma	0.000371	0.000478	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—SMO—meningioma	0.000365	0.000471	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—SMO—meningioma	0.00036	0.000463	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—PDGFB—meningioma	0.000357	0.00046	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—ALAD—meningioma	0.000351	0.000453	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—TSHB—meningioma	0.000349	0.00045	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—PLAU—meningioma	0.000346	0.000446	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—ERBB2—meningioma	0.000341	0.00044	CbGpPWpGaD
Carvedilol—ABCB1—HIF-1-alpha transcription factor network—AKT1—meningioma	0.000337	0.000434	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—ALAD—meningioma	0.000331	0.000427	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—SMO—meningioma	0.000319	0.000412	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—TSHB—meningioma	0.000304	0.000391	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—TSHB—meningioma	0.000303	0.000391	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TSHB—meningioma	0.000301	0.000388	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—SMO—meningioma	0.000297	0.000383	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.000293	0.000378	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—AKT1—meningioma	0.000293	0.000377	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—PTEN—meningioma	0.000291	0.000375	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—PDGFB—meningioma	0.00029	0.000374	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—PLAU—meningioma	0.000281	0.000363	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TSHB—meningioma	0.000274	0.000354	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TSHB—meningioma	0.000272	0.00035	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TSHB—meningioma	0.000268	0.000346	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—ALAD—meningioma	0.000265	0.000341	CbGpPWpGaD
Carvedilol—NDUFC2—Metabolism—AKT1—meningioma	0.00026	0.000335	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—HES1—meningioma	0.000257	0.000332	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—HES1—meningioma	0.000257	0.000331	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—SMO—meningioma	0.000256	0.00033	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TSHB—meningioma	0.000254	0.000327	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—TP53—meningioma	0.000253	0.000326	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TSHB—meningioma	0.00025	0.000322	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.00025	0.000322	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—ALAD—meningioma	0.000249	0.000321	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—ALAD—meningioma	0.000247	0.000319	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—TSHB—meningioma	0.000247	0.000318	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—PGR—meningioma	0.000245	0.000316	CbGpPWpGaD
Carvedilol—ADRA2B—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000244	0.000315	CbGpPWpGaD
Carvedilol—HIF1A—Disease—AKT1—meningioma	0.00024	0.000309	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—SMO—meningioma	0.000233	0.000301	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—SMO—meningioma	0.000231	0.000298	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—SMO—meningioma	0.000228	0.000294	CbGpPWpGaD
Carvedilol—ADRA2C—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000228	0.000294	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—TSHB—meningioma	0.000226	0.000292	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—PGR—meningioma	0.000224	0.000288	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TSHB—meningioma	0.000222	0.000286	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—PGR—meningioma	0.000221	0.000286	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—PDGFB—meningioma	0.00022	0.000284	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—PDGFB—meningioma	0.00022	0.000283	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—PGR—meningioma	0.000219	0.000282	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—AKT1—meningioma	0.000218	0.000281	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—SMO—meningioma	0.000216	0.000278	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—AKT1—meningioma	0.000213	0.000275	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—TSHB—meningioma	0.000213	0.000275	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—SMO—meningioma	0.000212	0.000274	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ALAD—meningioma	0.000211	0.000272	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—PGR—meningioma	0.000207	0.000267	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TSHB—meningioma	0.000206	0.000266	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—PGR—meningioma	0.000204	0.000263	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—TP53—meningioma	0.000199	0.000256	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—SMO—meningioma	0.000189	0.000243	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000185	0.000239	CbGpPWpGaD
Carvedilol—ADRA2A—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000185	0.000239	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—PGR—meningioma	0.000181	0.000233	CbGpPWpGaD
Carvedilol—XDH—Metabolism—PTEN—meningioma	0.000176	0.000227	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—SMO—meningioma	0.000175	0.000226	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—TSHB—meningioma	0.00017	0.00022	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.00017	0.00022	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PGR—meningioma	0.000168	0.000217	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—AKT1—meningioma	0.000168	0.000216	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—HES1—meningioma	0.000168	0.000216	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ALAD—meningioma	0.000163	0.00021	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—TSHB—meningioma	0.000161	0.000207	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—TSHB—meningioma	0.000159	0.000205	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—HES1—meningioma	0.000153	0.000197	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—HES1—meningioma	0.000151	0.000195	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—HES1—meningioma	0.000149	0.000193	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—TP53—meningioma	0.000149	0.000192	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—ERBB2—meningioma	0.000148	0.00019	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—ERBB2—meningioma	0.000147	0.00019	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000144	0.000186	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—PDGFB—meningioma	0.000143	0.000185	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—HES1—meningioma	0.000141	0.000182	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—HES1—meningioma	0.000139	0.000179	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—TP53—meningioma	0.000139	0.000179	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—TSHB—meningioma	0.000136	0.000175	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—AKT1—meningioma	0.000135	0.000174	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—PDGFB—meningioma	0.000131	0.000169	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000131	0.000168	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—PDGFB—meningioma	0.00013	0.000167	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—PDGFB—meningioma	0.000128	0.000165	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—PTEN—meningioma	0.000126	0.000162	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—AKT1—meningioma	0.000126	0.000162	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—PTEN—meningioma	0.000126	0.000162	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—HES1—meningioma	0.000124	0.000159	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—AKT1—meningioma	0.000123	0.000158	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—PDGFB—meningioma	0.000121	0.000156	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—PDGFB—meningioma	0.000119	0.000153	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—AKT1—meningioma	0.000118	0.000152	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—HES1—meningioma	0.000115	0.000148	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—TP53—meningioma	0.000113	0.000146	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—PDGFB—meningioma	0.000106	0.000136	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—TSHB—meningioma	0.000105	0.000135	CbGpPWpGaD
Carvedilol—XDH—Metabolism—AKT1—meningioma	0.000102	0.000131	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PDGFB—meningioma	9.83e-05	0.000127	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—meningioma	9.74e-05	0.000126	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—ERBB2—meningioma	9.61e-05	0.000124	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—AKT1—meningioma	9.55e-05	0.000123	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—AKT1—meningioma	8.81e-05	0.000114	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—ERBB2—meningioma	8.76e-05	0.000113	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—ERBB2—meningioma	8.68e-05	0.000112	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—TP53—meningioma	8.59e-05	0.000111	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—TP53—meningioma	8.57e-05	0.000111	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—ERBB2—meningioma	8.57e-05	0.00011	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—meningioma	8.32e-05	0.000107	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—PTEN—meningioma	8.27e-05	0.000107	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—PTEN—meningioma	8.25e-05	0.000106	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—PTEN—meningioma	8.2e-05	0.000106	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—ERBB2—meningioma	8.11e-05	0.000105	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—AKT1—meningioma	8.03e-05	0.000103	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—AKT1—meningioma	8e-05	0.000103	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—ERBB2—meningioma	7.98e-05	0.000103	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—AKT1—meningioma	7.95e-05	0.000103	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—AKT1—meningioma	7.85e-05	0.000101	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—PTEN—meningioma	7.47e-05	9.63e-05	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—AKT1—meningioma	7.43e-05	9.58e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—PTEN—meningioma	7.4e-05	9.54e-05	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—AKT1—meningioma	7.31e-05	9.42e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—PTEN—meningioma	7.31e-05	9.42e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—AKT1—meningioma	7.29e-05	9.4e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—AKT1—meningioma	7.25e-05	9.35e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—AKT1—meningioma	7.24e-05	9.33e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—AKT1—meningioma	7.22e-05	9.31e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—AKT1—meningioma	7.13e-05	9.19e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—ERBB2—meningioma	7.09e-05	9.14e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—PTEN—meningioma	6.91e-05	8.91e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—PTEN—meningioma	6.8e-05	8.77e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—AKT1—meningioma	6.75e-05	8.7e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PTEN—meningioma	6.72e-05	8.66e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—AKT1—meningioma	6.64e-05	8.56e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—ERBB2—meningioma	6.59e-05	8.49e-05	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—AKT1—meningioma	6.49e-05	8.37e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PTEN—meningioma	6.17e-05	7.95e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—PTEN—meningioma	6.04e-05	7.79e-05	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—AKT1—meningioma	6.03e-05	7.78e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—AKT1—meningioma	5.9e-05	7.6e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PTEN—meningioma	5.81e-05	7.5e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PTEN—meningioma	5.62e-05	7.24e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TP53—meningioma	5.6e-05	7.21e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—AKT1—meningioma	5.48e-05	7.06e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TP53—meningioma	5.1e-05	6.57e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TP53—meningioma	5.05e-05	6.51e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TP53—meningioma	4.99e-05	6.43e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—AKT1—meningioma	4.77e-05	6.14e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—AKT1—meningioma	4.76e-05	6.13e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—AKT1—meningioma	4.72e-05	6.09e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TP53—meningioma	4.72e-05	6.08e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PTEN—meningioma	4.64e-05	5.99e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TP53—meningioma	4.64e-05	5.99e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PTEN—meningioma	4.38e-05	5.64e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PTEN—meningioma	4.34e-05	5.59e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—AKT1—meningioma	4.31e-05	5.55e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—AKT1—meningioma	4.27e-05	5.5e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—AKT1—meningioma	4.21e-05	5.43e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TP53—meningioma	4.12e-05	5.32e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—AKT1—meningioma	3.98e-05	5.14e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—AKT1—meningioma	3.92e-05	5.06e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—AKT1—meningioma	3.87e-05	4.99e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TP53—meningioma	3.83e-05	4.94e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PTEN—meningioma	3.71e-05	4.78e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—AKT1—meningioma	3.55e-05	4.58e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—AKT1—meningioma	3.48e-05	4.49e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—AKT1—meningioma	3.35e-05	4.32e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—AKT1—meningioma	3.24e-05	4.17e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PTEN—meningioma	2.86e-05	3.69e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—AKT1—meningioma	2.68e-05	3.45e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—AKT1—meningioma	2.52e-05	3.25e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—AKT1—meningioma	2.5e-05	3.22e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—AKT1—meningioma	2.14e-05	2.75e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—AKT1—meningioma	1.65e-05	2.13e-05	CbGpPWpGaD
